Delivery Order SPE2DB20D6036-SPE2DB24FC8PG

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablet in 8-count packaging. The $11,342.10 firm-fixed-price contract has a completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $11,071.03, is for the delivery of Nurtec ODT 75 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of October 15, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Nurtec ODT 75 mg tablets. The $16,608.61 firm-fixed-price contract has an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other federal healthcare programs. This award is associated with AmerisourceBergen's Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,687.76 firm-fixed-price contract is for the supply of Nurtec ODT 75 mg tablets. The award has an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to provide a wide range of pharmaceutical and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $8,301.49. The order is for Nurtec ODT 75 mg tablets and is a firm fixed-price contract. The ultimate completion date is September 17, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other agencies, such as the Department of Justice Federal Bureau of Investigation, to supply a range of essential...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Nurtec ODT 75 mg tablets and has a ceiling value of $15,359.33. The contract type is Firm Fixed Price and the performance period extends to May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,942.95 firm fixed-price contract is for the delivery of Nurtec ODT 75 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The $8,341.15 contract has a completion date of July 22, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Nurtec ODT 75 mg tablets. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $88,287.54. The ultimate completion date is June 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $54,112.28 firm-fixed-price contract is for the delivery of Nurtec ODT 75 mg tablets, a neurological medication. The contract has a period of performance through May 5, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
  • SPE2DB20D6036
    Indefinite Delivery Contract
  • SPE2DB20D6036-SPE2DB24FC8PG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,462.80 firm-fixed-price contract is for the supply of Nurtec ODT 75 mg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, for delivering a wide range of medical commodities, including pharmaceutical products, to support military treatment programs and federal healthcare providers. This award does not have a set-aside designation.

Generated 10/31/24, 10:14 AM